Company overview
Basic information
Company name
LINKRIS, UAB
Company code
300603161
VAT code
LT100002866310
Registered address
Vilnius, Smolensko g. 10-89, LT-03201
Registration date
2006-09-28
Company age: 20 y. 1 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Activities of call centres
Ownership form
Private without foreign capital
UAB "LINKRIS"
Company code: 300603161
Address: Vilnius, Smolensko g. 10-89, LT-03201
VAT code: LT100002866310
Description
This description was generated by artificial intelligence.
LINKRIS, UAB (company code 300603161) is an operational private limited liability company registered in 2006 and located in Vilnius, Smolensko g. 10-89, Vilniaus m. sav., Vilniaus apskr. It operates in the sector of national private non-financial companies and is classified as a privately owned business with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Governance is listed as CEO only, and the company is assessed as medium-sized. Its main activity under EVRK code O.82.20.00 is Activities of call centres. In financial year 2025, the company generated revenue of €2.09 million and net profit of €45.6 thousand, with a profit margin of 2.2%. Revenue was 2.2% lower than in 2024, but still 11.2% above the 2023 level. At the end of 2025, equity stood at €93.5 thousand, liabilities at €548.1 thousand, and total assets at €638.0 thousand. On the staffing side, the company employed 157 people on average so far in 2026, down from 259 in 2025, while the average monthly wage increased to €1,176.07 so far in 2026 from €1,134.88 in 2025.
Download a detailed company report
Make confident decisions with all the information about LINKRIS, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.